Apical versus Non-Apical Lead: Is ICD Lead Position Important for Successful Defibrillation?
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu srovnávací studie, časopisecké články, multicentrická studie, randomizované kontrolované studie, práce podpořená grantem
PubMed
26888558
DOI
10.1111/jce.12952
Knihovny.cz E-zdroje
- Klíčová slova
- cardiac resynchronization therapy, defibrillation safety margin, defibrillation testing, failed shocks, implantable cardioverter defibrillator, inappropriate shocks, right ventricular lead,
- MeSH
- časové faktory MeSH
- defibrilátory implantabilní * MeSH
- elektrická defibrilace škodlivé účinky přístrojové vybavení metody mortalita MeSH
- elektrofyziologické techniky kardiologické MeSH
- Kaplanův-Meierův odhad MeSH
- kardiostimulace umělá MeSH
- lidé středního věku MeSH
- lidé MeSH
- logistické modely MeSH
- náhlá srdeční smrt etiologie MeSH
- proporcionální rizikové modely MeSH
- prospektivní studie MeSH
- protézy - design MeSH
- rizikové faktory MeSH
- selhání protézy MeSH
- senioři MeSH
- srdeční arytmie komplikace diagnóza mortalita terapie MeSH
- tendenční skóre MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
- srovnávací studie MeSH
INTRODUCTION: We aim to compare the acute and long-term success of defibrillation between non-apical and apical ICD lead position. METHODS AND RESULTS: The position of the ventricular lead was recorded by the implanting physician for 2,475 of 2,500 subjects in the Shockless IMPLant Evaluation (SIMPLE) trial, and subjects were grouped accordingly as non-apical or apical. The success of intra-operative defibrillation testing and of subsequent clinical shocks were compared. Propensity scoring was used to adjust for the impact of differences in baseline variables between these groups. There were 541 leads that were implanted at a non-apical position (21.9%). Patients implanted with a non-apical lead had a higher rate of secondary prevention indication. Non-apical location resulted in a lower mean R-wave amplitude (14.0 vs. 15.2, P < 0.001), lower mean pacing impedance (662 ohm vs. 728 ohm, P < 0.001), and higher mean pacing threshold (0.70 V vs. 0.66 V, P = 0.01). Single-coil leads and cardiac resynchronization devices were used more often in non-apical implants. The success of intra-operative defibrillation was similar between propensity score matched groups (89%). Over a mean follow-up of 3 years, there were no significant differences in the yearly rates of appropriate shock (5.5% vs. 5.4%, P = 0.98), failed appropriate first shock (0.9% vs. 1.0%, P = 0.66), or the composite of failed shock or arrhythmic death (2.8% vs. 2.3% P = 0.35) according to lead location. CONCLUSION: We did not detect any reduction in the ICD efficacy at the time of implant or during follow-up in patients receiving a non-apical RV lead.
Boston Scientific Brussels Belgium
Boston Scientific Minneapolis Minnesota USA
Centre Hospitalier Universitaire Rennes France
CHU Hopital Michallon Grenoble France
Hospital de Santa Creu i Sant Pau Barcelona Spain
Institut Universitaire de Cardiologie et de Pneumologie de Québec Québec Canada
Institute for Clinical and Experimental Medicine Prague Czech Republic
J W Goethe University Frankfurt Germany
Karolinska Institute Stockholm Sweden
Klinikum Coburg GbmH Coburg Germany
Klinikum Kassel Kassel Germany
Leiden University Medical Center Leiden the Netherlands
Leviev Heart Center Sheba Medical Center Tel Hashomer Israel
Liverpool Heart and Chest Hospital Liverpool UK
Soroka Medical Center Ben Gurion University Beer Sheva Israel
Citace poskytuje Crossref.org